Pfizer and BioNTech have submitted an emergency-use authorization request to the FDA for their two-dose COVID-19 vaccine regimen for 6-month-olds to 5-year-olds, The Washington Post reported Feb. 1.
Read the full post on Becker's Hospital Review - Healthcare News
